Princeton Baptist Medical Center Receives American Heart Association Get With The Guidelines Stroke Care Achievement AwardSep 17, 2021
Award recognizes Princeton Baptist’s commitment to quality care in the treatment of stroke
BIRMINGHAM, ALA. - Princeton Baptist Medical Center today announced it received the American Heart Association/American Stroke Association’s Get With The Guidelines® Target: Stroke Honor Roll Elite Gold Plus Quality Achievement Award. The award recognizes the hospital’s commitment to ensuring stroke patients receive the most appropriate treatment according to nationally recognized, research-based guidelines based on the latest scientific evidence.
Princeton Baptist Medical Center earned the award by meeting specific quality achievement measures for the diagnosis and treatment of stroke patients at a set level for a designated period. These measures include evaluation of the proper use of medications and other stroke treatments aligned with the most up-to-date, evidence-based guidelines with the goal of speeding recovery and reducing death and disability for stroke patients. Before discharge, patients should also receive education on managing their health, get a follow-up visit scheduled, as well as other care transition interventions.
Additionally, Princeton Baptist received the Association’s Target: Type 2 Diabetes Honor Roll award. To qualify for this recognition, hospitals must meet quality measures developed with more than 90% of compliance for 12 consecutive months for the “Overall Diabetes Cardiovascular Initiative Composite Score.”
According to Mike Neuendorf, CEO of Princeton Baptist Medical Center, “This award continues to define our hospital as setting the standard in the treatment of stroke, and we are extremely proud of this achievement that reaffirms to our patients they can rely on Princeton Baptist Medical Center to provide the highest level of care.”
Princeton Baptist Medical Center additionally received the association’s Target: StrokeSM Elite award. To qualify for this recognition, hospitals must meet quality measures developed to reduce the time between the patient’s arrival at the hospital and treatment with the clot-buster tissue plasminogen activator, or tPA, the only drug approved by the U.S. Food and Drug Administration to treat ischemic stroke.
“We are pleased to recognize Princeton Baptist Medical Center for its commitment to stroke care,” said Lee H. Schwamm, M.D., national chairperson of the Quality Oversight Committee and executive vice chair of Neurology, director of Acute Stroke Services, Massachusetts General Hospital, Boston, Massachusetts. “Research has shown that hospitals adhering to clinical measures through the Get With The Guidelines quality improvement initiative can often see fewer readmissions and lower mortality rates.”
According to the American Heart Association/American Stroke Association, stroke is the No. 5 cause of death and a leading cause of adult disability in the United States. On average, someone in the U.S. suffers a stroke every 40 seconds and nearly 795,000 people suffer a new or recurrent stroke each year.